Search
Ledipasvir
go.drugbank.com/drugs/DB09027ApprovedIt is effective against genotypes 1a, 1b, 4a, and 5a and with a lesser activity against genotypes 2a and 3a of HCV. … Although its exact mechanism of action is unknown, it is postulated to prevent hyperphosphorylation of NS5A which is required for viral protein production.
Mixtures: HARVONI 90 MG/400 MG FILM KAPLI TABLET, 84 ADET, HARVONI 90 MG/400 MG FILM KAPLI TABLET, 28 ADETMelphalan
go.drugbank.com/drugs/DB01042ApprovedInvestigational[L40928] It is also used for high-conditioning before hematopoietic stem cell transplant.[L47890] It is also used to treat uveal melanoma with unresectable hepatic metastases.[L47895] … [L40928] It was first synthesized in the early 1950s by substituting L-phenylalanine for the methyl group on nitrogen mustard.
Products: Alkeran Tablets 2mg, ALKERAN® 2 MG TABLETASTeclistamab
go.drugbank.com/drugs/DB16655ApprovedInvestigationalcells to promote T cell–mediated cytotoxicity. … [A253587] On August 24, 2022, the European Commission (EC) granted conditional marketing authorization of teclistamab as first-in-class bispecific antibody for the treatment of multiple myeloma, marking
Categories: Bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engagerCefoperazone
go.drugbank.com/drugs/DB01329ApprovedInvestigationalWithdrawnIt is a third-generation antiobiotic agent and it is used in the treatment of various bacterial infections caused by susceptible organisms in the body, including respiratory tract infections, peritonitis
Mixtures: PRİMASEF 500 MG IM/IV ENJEKSİYONLUK TOZ İÇEREN FLAKON, 1 ADET, PRİMASEF 1000 MG IM/IV ENJEKSİYONLUK TOZ İÇEREN FLAKON, 1 ADETSynonyms: (6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeureLisdexamfetamine
go.drugbank.com/drugs/DB01255ApprovedInvestigational[A2230] It was also approved by Health Canada in February 2009.
Products: SAMEXID 70 MG, VYVANSE CAPSULES 20 mgMomelotinib
go.drugbank.com/drugs/DB11763ApprovedInvestigationalMF includes primary MF (PMF), post-polycythemia vera (PV) MF, and post-essential thrombocythemia (ET) MF. Clinical manifestations of MF include anemia and thrombocytosis. … It is a competitive inhibitor of JAK ATP binding.[A261566] First approved by the FDA on September 15, 2023,[L48206] momelotinib is used to treat myelofibrosis.
Methionine
go.drugbank.com/drugs/DB00134ApprovedInvestigationalNutraceuticalIt is a chelating agent for heavy metals.
Mixtures: Clinimix E, Clinimix ESynonyms: MetSodium glycerophosphate
go.drugbank.com/drugs/DB09561ApprovedIt is used clinically to treat or prevent low phosphate levels [FDA Label]. Glycerophosphate is hydrolyzed to inorganic phosphate and glycerol in the body [A32667].
Mixtures: Olimel 7.6% E, Olimel 4.4% EProducts: GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/mlTyrosine
go.drugbank.com/drugs/DB00135ApprovedInvestigationalNutraceuticalIn animals it is synthesized from [phenylalanine]. It is also the precursor of [epinephrine], thyroid hormones, and melanin.
Mixtures: Clinimix E, Clinimix ETegaserod
go.drugbank.com/drugs/DB01079ApprovedWithdrawn[L5918,F4229] It was, however, voluntarily withdrawn from widespread use in the US market in 2007 after concerns arose over the possibility that tegaserod could potentially cause dangerous cardiovascular … in its history of regulatory approval, ever since its first introduction in 2002 tegaserod remains the only therapy for IBS-C that possesses the unique mechanism of action of acting on serotonin-4 (5-HT